UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Efficacy of a Fourth Dose of Covid-19 mRNA Vaccine against Omicron

The New England journal of medicine, 2022-04, Vol.386 (14), p.1377-1380

2022

Volltextzugriff (PDF)

Six-Month Follow-up after a Fourth BNT162b2 Vaccine Dose

The New England journal of medicine, 2022-12, Vol.387 (22), p.2092-2094

2022

Volltextzugriff (PDF)

Superior immunogenicity and effectiveness of the third compared to the second BNT162b2 vaccine dose

Nature immunology, 2022-06, Vol.23 (6), p.940-946

2022

Volltextzugriff (PDF)

Early Immunogenicity and Safety of the Third Dose of BNT162b2 Messenger RNA Coronavirus Disease 2019 Vaccine Among Adults Older Than 60 Years: Real-World Experience

The Journal of infectious diseases, 2022-03, Vol.225 (5), p.785-792

2022

Volltextzugriff (PDF)

The Association Between Prebooster Vaccination Antibody Levels and the Risk of Severe Acute Respiratory Syndrome Coronavirus 2 Infection

Clinical infectious diseases, 2023-04, Vol.76 (7), p.1315-1317

2023

Volltextzugriff (PDF)

Immunogenicity and efficacy of fourth BNT162b2 and mRNA1273 COVID-19 vaccine doses; three months follow-up

Nature communications, 2022-12, Vol.13 (1), p.7711-7711, Article 7711

2022

Volltextzugriff (PDF)

Telmisartan Modulates Glial Activation: In Vitro and In Vivo Studies

PloS one, 2016-05, Vol.11 (5), p.e0155823-e0155823

2016

Volltextzugriff (PDF)

SARS-CoV-2 IgG Levels as Predictors of XBB Variant Neutralization, Israel, 2022- and 2023

Emerging infectious diseases, 2024-05, Vol.30 (5), p.1050-1052

2024

Volltextzugriff (PDF)

Microglial Activation Is Modulated by Captopril: in Vitro and in Vivo Studies

Frontiers in cellular neuroscience, 2018-05, Vol.12, p.116-116

2018

Volltextzugriff (PDF)

Author Correction: Immunogenicity and efficacy of fourth BNT162b2 and mRNA1273 COVID-19 vaccine doses; three months follow-up

Nature communications, 2023-03, Vol.14 (1), p.1593-1593, Article 1593

2023

Volltextzugriff (PDF)

miR-155: A Potential Biomarker for Predicting Mortality in COVID-19 Patients

Journal of personalized medicine, 2022-02, Vol.12 (2), p.324

2022

Volltextzugriff (PDF)

High Immune Response Rate to the Fourth Boost of the BNT162b2 Vaccine against the Omicron Variants of Concern among Liver Transplant Recipients

Viruses, 2022-12, Vol.14 (12), p.2769

2022

Volltextzugriff (PDF)

Involvement of the Bradykinin B1 Receptor in Microglial Activation: In Vitro and In Vivo Studies

Frontiers in endocrinology (Lausanne), 2017-04, Vol.8, p.82-82

2017

Volltextzugriff (PDF)

Reduced Neutralization Efficacy against Omicron Variant after Third Boost of BNT162b2 Vaccine among Liver Transplant Recipients

Viruses, 2023-01, Vol.15 (1), p.253

2023

Volltextzugriff (PDF)

Correlation between Adverse Events and Antibody Titers among Healthcare Workers Vaccinated with BNT162b2 mRNA COVID-19 Vaccine

Vaccines (Basel), 2022-07, Vol.10 (8), p.1220

2022

Volltextzugriff (PDF)

Low FXIII activity levels in intensive care unit hospitalized COVID-19 patients

Thrombosis journal, 2021-11, Vol.19 (1), p.1-79, Article 79

2021

Volltextzugriff (PDF)

Early Adverse Events and Immune Response Following Second and Third COVID-19 Vaccination in Pregnancy

Journal of clinical medicine, 2022-08, Vol.11 (16), p.4720

2022

Volltextzugriff (PDF)

Maternal and Neonatal Immune Responses Following COVID-19 Infection and Vaccinations in Pregnancy

Vaccines (Basel), 2022-11, Vol.10 (12), p.2019

2022

Volltextzugriff (PDF)

Real-World Immunogenicity and Reactogenicity of Two Doses of Pfizer-BioNTech COVID-19 Vaccination in Children Aged 5–11 Years

Vaccines (Basel), 2022-11, Vol.10 (11), p.1954

2022

Volltextzugriff (PDF)

Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 Months

The New England journal of medicine, 2021-12, Vol.385 (24), p.e84-e84

2021

Volltextzugriff (PDF)

The Predictive Value of Serum ACE2 and TMPRSS2 Concentrations in Patients with COVID-19-A Prospective Pilot Study

Journal of personalized medicine, 2022-04, Vol.12 (4), p.622

2022

Volltextzugriff (PDF)

Potential Antigenic Cross-reactivity Between Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Dengue Viruses

Clinical infectious diseases, 2021-10, Vol.73 (7), p.e2444-e2449

2021

Volltextzugriff (PDF)

Superior immunogenicity and effectiveness of the third compared to the second BNT162b2 vaccine dose

Nature immunology, 2022-06, Vol.23 (6), p.940

2022

Volltextzugriff (PDF)

Candesartan ameliorates brain inflammation associated with Alzheimer's disease

CNS neuroscience & therapeutics, 2018-03, Vol.24 (3), p.231-242

2018

Volltextzugriff (PDF)

Intranasal Telmisartan Ameliorates Brain Pathology in Five Familial Alzheimer's Disease Mice

Brain, behavior, and immunity, 2017-08, Vol.64, p.80-90

2017

Volltextzugriff (PDF)

1 – 25 von 46

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(45)
Mit Volltextzugriff
(40)

Publikationsform

Artikel
(46)

Sprache

Englisch
(46)

Erscheinungsjahr

n.n

Thema

Science & Technology
(37)
Life Sciences & Biomedicine
(35)
Humans
(20)
Covid-19
(18)
Severe Acute Respiratory Syndrome Coronavirus 2
(17)
Antibodies
(15)
Vaccines
(15)
Immunoglobulin G
(14)
Infections
(14)
Coronaviruses
(13)
Covid-19 Vaccines
(13)
Immunology
(13)
Covid-19 - Prevention & Control
(11)
Female
(10)
Infectious Diseases
(10)
Sars-Cov-2
(10)
General & Internal Medicine
(9)
Male
(9)
Medical Personnel
(9)
Medicine, General & Internal
(9)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Efficacy of a Fourth Dose of Covid-19 mRNA Vaccine against Omicron

Six-Month Follow-up after a Fourth BNT162b2 Vaccine Dose

Superior immunogenicity and effectiveness of the third compared to the second BNT162b2 vaccine dose

Early Immunogenicity and Safety of the Third Dose of BNT162b2 Messenger RNA Coronavirus Disease 2019 Vaccine Among Adults Older Than 60 Years: Real-World Experience

The Association Between Prebooster Vaccination Antibody Levels and the Risk of Severe Acute Respiratory Syndrome Coronavirus 2 Infection

Immunogenicity and efficacy of fourth BNT162b2 and mRNA1273 COVID-19 vaccine doses; three months follow-up

Telmisartan Modulates Glial Activation: In Vitro and In Vivo Studies

SARS-CoV-2 IgG Levels as Predictors of XBB Variant Neutralization, Israel, 2022- and 2023

Microglial Activation Is Modulated by Captopril: in Vitro and in Vivo Studies

Author Correction: Immunogenicity and efficacy of fourth BNT162b2 and mRNA1273 COVID-19 vaccine doses; three months follow-up

miR-155: A Potential Biomarker for Predicting Mortality in COVID-19 Patients

High Immune Response Rate to the Fourth Boost of the BNT162b2 Vaccine against the Omicron Variants of Concern among Liver Transplant Recipients

Involvement of the Bradykinin B1 Receptor in Microglial Activation: In Vitro and In Vivo Studies

Reduced Neutralization Efficacy against Omicron Variant after Third Boost of BNT162b2 Vaccine among Liver Transplant Recipients

Correlation between Adverse Events and Antibody Titers among Healthcare Workers Vaccinated with BNT162b2 mRNA COVID-19 Vaccine

Low FXIII activity levels in intensive care unit hospitalized COVID-19 patients

Early Adverse Events and Immune Response Following Second and Third COVID-19 Vaccination in Pregnancy

Maternal and Neonatal Immune Responses Following COVID-19 Infection and Vaccinations in Pregnancy

Real-World Immunogenicity and Reactogenicity of Two Doses of Pfizer-BioNTech COVID-19 Vaccination in Children Aged 5–11 Years

Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 Months

The Predictive Value of Serum ACE2 and TMPRSS2 Concentrations in Patients with COVID-19-A Prospective Pilot Study

Potential Antigenic Cross-reactivity Between Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Dengue Viruses

Superior immunogenicity and effectiveness of the third compared to the second BNT162b2 vaccine dose

Candesartan ameliorates brain inflammation associated with Alzheimer's disease

Intranasal Telmisartan Ameliorates Brain Pathology in Five Familial Alzheimer's Disease Mice

Suchergebnisse filtern